GF
OPNT

Gabelli Funds’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Gabelli Funds’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-37,119
Closed -$753K – 1231
2022
Q4 		$753K Buy
+37,119
New +$569K 0.01% 858

Gabelli Funds's OPNT Position: Q1 2023 in Review

Gabelli Funds sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 37,119 shares — an estimated $753K sold.

Gabelli Funds first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $753K in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

  • Gabelli Funds reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Gabelli Funds sold 37,119 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $753K.
  • Gabelli Funds first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Gabelli Funds's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $753K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Gabelli Funds's 13F filing for Q1 2023, filed 12 May 2023.